Bearcat Basketball Halftime Ceremony Honors UC Recipient of "American Nobel"

Dr. Elwood Jensen’s research led to a discovery that transformed the treatment of breast cancer patients and saves more than 100,000 lives each year. UC’s second recipient of the Lasker Award, known as the “American Nobel,” will be honored at a special halftime ceremony at the UC/Houston men’s basketball game Saturday, Jan. 29, at Fifth Third Arena. The game begins at 7 p.m.

UC President Nancy L. Zimpher, PhD, and Senior Vice President and Provost for Health Affairs Jane E. Henney, MD, will take part in the ceremony that celebrates Dr. Jensen’s Lasker Award, a highly respected recognition that has honored scientific accomplishments for 56 years.

Dr. Jensen, the George J. and Elizabeth Wile Chair in Cancer Research at UC, is a distinguished university professor in the Department of Cell Biology, Neurobiology and Anatomy.

The Lasker Awards are the most coveted prize in biomedical research. Ohio has only two Lasker Award recipients, Dr. Jensen and UC’s Albert Sabin, MD, who developed the world’s first oral polio vaccine.

Tags

Related Stories

1

Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December

December 12, 2025

This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.

2

Ohio nurses weigh in on proposed federal loan rule

December 12, 2025

Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.

3

New combination treatment improves multiple myeloma outcomes

December 11, 2025

The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.